A Phase 3 trial of serlopitant for the treatment of pruritus associated with prurigo nodularis

Trial Profile

A Phase 3 trial of serlopitant for the treatment of pruritus associated with prurigo nodularis

Planning
Phase of Trial: Phase III

Latest Information Update: 25 Oct 2017

At a glance

  • Drugs Serlopitant (Primary)
  • Indications Prurigo nodularis; Pruritus
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Oct 2017 New trial record
    • 17 Oct 2017 According to a Menlo Therapeutics Inc media release, the company expects to start this trial in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top